Hummingbird Bioscience bags $35.3m in series B funding round

SK Holdings led the series B extension as a new investor.

Biotherapeutics company, Hummingbird Bioscience, has closed an extended series B funding round of $35.3m (US$25m), according to an announcement, bringing the company's total capital raised through financing activities and strategic partnerships to more than $91.78m (US$65m).

SK Holdings led the series B extension as a new investor, with participation from existing shareholders, including Heritas Capital and SEEDS Capital, the investment arm of Enterprise Singapore.

The extension of the series B round to $35.3m (US$25m) is said to be due to over-subscription, with the addition of select quality and value-add investors.

Hummingbird will use the new funds to accelerate development of new candidates into clinical trials and strengthen its scientific and research and development capabilities.

Earlier this year, Hummingbird announced publication of positive data on its lead candidate, HMBD-001, a unique HER3 antibody, and manufacturing of HMBD-002, a first-in-class VISTA antibody. Regulatory submissions to initiate Phase I studies for these are expected in H2 2020.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia